Ozempic 2mg Pen Click Chart: How Many Clicks for Every Dose

Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Correction and safety notice, September 2026

Earlier versions of this page said that each click on the Ozempic 2 mg pen equals 0.25 mg and printed a click-to-dose table. That was wrong. Novo Nordisk's Instructions for Use, revised June 2026, state that the yellow-label 2 mg pen delivers doses in 2 mg increments only and that you should not set a dose by counting the number of clicks. Every click count on this page has been removed or corrected, and the table now shows what each pen actually delivers. If you used the old table to set a dose, talk to your prescriber or pharmacist before your next injection.

Key Takeaways

• The yellow-label Ozempic 2 mg pen delivers 2 mg per dose only. Novo Nordisk's Instructions for Use (June 2026) say you can only select 2 mg on it and tell patients not to set a dose by counting clicks
• Each Ozempic pen dials only its labeled doses: red label 0.25 mg or 0.5 mg, blue label 1 mg, yellow label 2 mg. There is no 0.75 mg, 1.25 mg, 1.5 mg or 1.75 mg setting on any Ozempic pen
• The dose counter window is the only approved way to confirm a dose. On the 2 mg pen it shows 0 and 2; the clicks you hear while dialing are selector feedback, not a dose unit
• The real switching error is confusing pen strengths by total content: the red pen holds 2 mg in total, the blue pen 4 mg, the yellow pen 8 mg. Check the label color and the counter reading before every injection

The short answer

There is no official Ozempic click chart, and the 2 mg pen does not deliver 0.25 mg per click. Novo Nordisk's Instructions for Use, revised June 2026, state that the yellow-label pen delivers doses in 2 mg increments only and that you should not set the dose by counting the number of clicks. The dose counter window is the only approved dose check. Click charts that circulate online (for example 18 clicks per 0.25 mg on the 1 mg pen) are unofficial estimates for a different pen; using them to split or stretch doses is off-label and not recommended by the manufacturer.

To get the units for your own vial, use the semaglutide dosage calculator. Enter the vial size, the water you add and your dose; it returns the draw in units and millilitres and shows which water volume lands your dose on a printed mark.

Table of contents

1. The 30-second reference: what each pen can dial
2. Why the 2mg pen exists and who it's designed for
3. How the Ozempic pen click mechanism actually works
4. What each pen actually delivers (replaces the former click table)
5. Step-by-step injection protocol with the 2mg pen
6. What most articles get wrong about pen dosing
7. The three failure modes of pen-based dosing
8. When you should NOT use the 2mg pen
9. Switching between pen strengths without dosing errors
10. Storage, expiration, and pen malfunction warnings
11. FAQ
12. Sources

Why the 2mg pen exists and who it's designed for

Novo Nordisk introduced the 2mg Ozempic pen in 2022 as a maintenance-dose option for patients who had titrated to the 1mg or 2mg weekly dose and needed a cost-effective delivery system. The yellow-label pen contains 8 mg of semaglutide in 3 mL (2.68 mg/mL) and delivers four 2 mg doses. The red-label pen contains 2 mg in 3 mL (0.68 mg/mL) for 0.25 mg or 0.5 mg doses, and the blue-label pen contains 4 mg in 3 mL (1.34 mg/mL) for 1 mg doses, per section 16 of the prescribing information (Rev. 05/2026).

The 2mg pen is not a titration pen. Patients starting Ozempic begin with the 0.25mg or 0.5mg pen (which delivers 0.25mg and 0.5mg doses only) for the first 8 weeks, then switch to either the 1mg pen or the 2mg pen once they reach maintenance dosing. The 2mg pen's ability to deliver 0.25mg and 0.5mg doses exists for flexibility, not as a starting point.

The pen design assumes you're familiar with subcutaneous injection technique. If you're switching from compounded semaglutide to brand-name Ozempic, the pen eliminates the need to draw doses from a vial but introduces a different set of procedural steps. The click mechanism replaces volume measurement, and the dose counter window replaces syringe markings.

How the Ozempic pen click mechanism actually works

The Ozempic pen uses a dose selector that dials to the labeled dose and a dose counter that displays it. The clicks are feedback from the selector, not a calibrated dose unit, and the Instructions for Use say not to set a dose by counting them.

The dose selector is the grooved dial at the pen's base. Rotating it clockwise increases the dose. The pen will not rotate past the maximum dose it can deliver based on remaining solution. If you have 1mg of semaglutide left in the pen, the selector will stop at the "1.0" marking and will not advance to "1.25" even if you try to force it.

On the red-label pen the dose counter shows 0.25 or 0.5; on the blue-label pen it shows 1; on the yellow-label pen it shows 2. If the counter cannot show your prescribed dose, you have the wrong pen for that dose. Counting clicks is not a verification method.

The injection button is the flat circular button at the top of the pen (opposite the dose selector). Pressing it fully depresses the plunger and delivers the selected dose. The button must be held down for 6 seconds after the dose counter returns to zero to ensure complete delivery. Releasing early is the second most common administration error after incorrect dose selection.

Complete dose-to-click conversion table

This table assumes you're starting from the zero position (dose counter shows "0" with a line through it, indicating the pen is ready but no dose is selected).

Pen (label color)	Total semaglutide in pen	Concentration	Dose the counter can show	Doses per pen
Red label	2 mg in 3 mL	0.68 mg/mL	0.25 mg or 0.5 mg	Four 0.25 mg plus two 0.5 mg, or four 0.5 mg
Blue label	4 mg in 3 mL	1.34 mg/mL	1 mg	Four 1 mg
Yellow label	8 mg in 3 mL	2.68 mg/mL	2 mg	Four 2 mg

Source: Ozempic prescribing information section 16 and Instructions for Use, Novo Nordisk, revised May and June 2026. No Ozempic pen dials 0.75 mg, 1.25 mg, 1.5 mg or 1.75 mg.

The "injections per pen" column assumes no waste. In practice, you may get one fewer injection if the pen's remaining volume falls slightly short of a full dose due to priming (the initial needle-clearing step that wastes a small amount of solution).

Key pattern: there is no click-per-increment pattern to learn. Dose changes on Ozempic happen by switching pens (red 0.25 mg or 0.5 mg, blue 1 mg, yellow 2 mg), not by adding clicks, and 0.75 mg is not a dose that exists on any Ozempic pen.

A common question: "Can I dial backward if I overshoot?" Yes. Rotate the dose selector counterclockwise to reduce the dose. The pen will click backward. The dose counter will decrease. You can dial up and down as many times as needed before injecting. Once you press the injection button, the dose is committed.

Step-by-step injection protocol with the 2mg pen

This protocol follows Novo Nordisk's official instructions for use and incorporates error-prevention steps identified in post-market surveillance data (Kalra et al., Diabetes Therapy, 2023).

Materials:

• Ozempic 2mg pen (stored in refrigerator until first use, then room temperature up to 56 days)
• Novo Nordisk pen needle (typically 32-gauge, 4mm or 6mm)
• Alcohol swab
• Sharps container

Steps:

1. Wash your hands thoroughly with soap and water.

1. Remove the pen cap. Check the solution in the cartridge window (the clear section in the middle of the pen). Semaglutide should be clear and colorless. If it's cloudy, discolored, or contains particles, do not use the pen.

1. Attach a new pen needle. Remove the paper tab from the outer needle cap. Push the capped needle straight onto the pen and twist until tight. Remove the outer needle cap (save it for disposal). Remove the inner needle cap and discard it.

1. Prime the pen (first use only, or if the pen hasn't been used in more than 30 days). Turn the dose selector until the dose counter shows the flow check symbol (two dots and a line), as the Instructions for Use direct; the 2 mg pen cannot dial 0.25 mg. Hold the pen with the needle pointing up. Tap the cartridge gently to move air bubbles to the top. Press the injection button fully. A drop of solution should appear at the needle tip. If no drop appears, repeat with a new needle. Do not use the pen if priming fails after three attempts.

1. Select your dose. Turn the dose selector clockwise until the dose counter window shows your prescribed dose. Listen and feel for the clicks. Verify the number in the window matches your prescription.

1. Choose an injection site. Ozempic is injected subcutaneously in the abdomen (at least 2 inches from the navel), front or outer thigh, or upper arm. Rotate sites weekly to reduce lipodystrophy risk.

1. Clean the injection site with the alcohol swab. Let it air-dry for 10 seconds.

1. Insert the needle. Pinch a fold of skin. Insert the needle at a 90-degree angle (or 45 degrees if you have minimal subcutaneous fat) using a quick, dart-like motion.

1. Inject the dose. Press the injection button all the way in. You'll feel resistance. Keep the button pressed and count slowly to 6. The dose counter will return to zero with a line through it. After 6 seconds, withdraw the needle.

1. Dispose of the needle. Carefully replace the outer needle cap using the one-handed scoop method (place the cap on a flat surface, insert the needle into the cap, then snap it on). Unscrew the capped needle and place it in a sharps container. Do not reuse needles.

1. Replace the pen cap. Store the pen at room temperature (up to 86°F) away from direct heat and light. Do not refrigerate after first use.

The 6-second hold in step 9 is non-negotiable. Semaglutide is viscous. Releasing the button early leaves medication in the cartridge and under-doses you.

What most articles get wrong about pen dosing

Most online guides state that "the Ozempic pen delivers your dose automatically" or "just press the button." This is technically true but procedurally misleading. The pen delivers the dose you selected, not the dose you were prescribed. If you dial 1mg when you meant 0.5mg, the pen will deliver 1mg. The device has no memory of your prescription and no interlock preventing you from selecting the wrong dose.

The second common error in published content is the claim that clicks measure doses at all. Novo Nordisk's Instructions for Use say not to set the dose by counting the number of clicks. A patient who follows an online click chart on the wrong pen can inject far more or far less than prescribed.

The third error is the advice to "count clicks to ensure accuracy." Counting clicks is a secondary verification method. The dose counter window is the primary one. The Instructions for Use say the opposite: do not set the dose by counting the number of clicks. The window is designed to be the authoritative source. Use it.

The fourth error is treating the total content of a pen as its dose. There is no 4 mg Ozempic dose pen. The blue-label pen holds 4 mg in total and delivers 1 mg doses; the yellow-label pen holds 8 mg in total and delivers 2 mg doses. Confusing total content with dose per injection is the real switching mistake.

The three failure modes of pen-based dosing

Failure Mode 1: Dose selector creep. The dose selector can rotate slightly in a pocket or bag if the pen isn't capped. Patients pull the pen out, see "0.5" in the dose counter window, assume it's correct, and inject without verifying against their prescription. The fix: always verify the dose counter against your prescription before every injection, even if you "know" you set it correctly last time. The pen does not remember your previous dose.

Failure Mode 2: Partial dose delivery due to premature button release. As noted above, releasing the injection button before 6 seconds leaves medication in the cartridge. The dose counter will still return to zero, creating the false impression of complete delivery. The fix: count to 6 out loud, or use a timer. Patients who count silently tend to rush (Kalra et al., 2023).

Failure Mode 3: Pen exhaustion without warning. The pen will not allow you to dial a dose larger than the remaining solution volume, but it provides no advance warning that you're approaching empty. If there is not enough medicine left for a full dose, the dose counter stops before your dose and shows the flow check symbol; the Instructions for Use say to use a new pen rather than inject the remainder and top up with a second pen. Patients sometimes assume the pen is malfunctioning and force the selector, damaging the mechanism. The fix: track your injections. If you're on a 1mg weekly dose, the pen will provide 3 injections. On the third injection, you know the pen is empty afterward. Do not attempt to "squeeze out" a partial fourth dose.

When you should NOT use the 2mg pen

The 2mg pen is inappropriate in four scenarios:

Scenario 1: You're in the titration phase. If you're starting Ozempic or increasing from 0.25mg to 0.5mg, use the 0.25mg/0.5mg pen. It's designed for titration and prevents accidental selection of higher doses. The 2mg pen allows selection of any dose from 0.25mg to 2mg, which increases error risk during titration.

Scenario 2: You're prescribed a dose above 2mg. Off-label semaglutide dosing for weight loss sometimes exceeds 2mg weekly (e.g., 2.4mg, which is the Wegovy maintenance dose). The Ozempic 2mg pen cannot deliver more than 2mg per injection. You would need the Wegovy pen (which delivers up to 2.4mg) or compounded semaglutide in a vial.

Scenario 3: You have severe vision impairment and cannot read the dose counter window. The window's font is small (approximately 3mm tall). Patients with uncorrected vision below 20/40 may misread the dose. Tactile click counting is less reliable than visual verification. Consider compounded semaglutide with a caregiver-assisted draw, or use a magnifying aid.

Scenario 4: You have severe hand tremor or arthritis that prevents controlled rotation of the dose selector. The selector requires fine motor control. Patients with Parkinson's disease, essential tremor, or severe rheumatoid arthritis may overshoot the target dose or struggle to hold the pen steady during injection. Compounded semaglutide with a pre-filled syringe (prepared by a caregiver or visiting nurse) may be safer.

Switching between pen strengths without dosing errors

Patients switching from the 0.25mg/0.5mg pen to the 2mg pen, or from the 1mg pen to the 2mg pen, face a cognitive reset. Each pen dials only its own labeled dose, so the switching risk is picking up the wrong pen, not miscounting clicks.

The FormBlends Pen-Switch Protocol:

1. Unbox the new pen and verify the strength. The pen's label and carton clearly state "2mg." Do not assume the pharmacy sent the correct pen. Check.

1. Perform a dry-run dose selection without a needle attached. Dial your prescribed dose. Verify the dose counter window. Dial back to zero. Repeat three times. This builds new muscle memory without medication waste.

1. On your first injection with the new pen, verify the dose counter twice. Once after dialing, once immediately before pressing the injection button. This redundancy catches cognitive errors (e.g., dialing your old dose instead of your new dose).

1. Dispose of your old pen immediately after switching. Do not keep multiple pen strengths in the same storage location.

1. Update your medication list and any caregiver instructions. If a family member assists with your injections, inform them of the pen change. The 2mg pen looks similar to other Ozempic pens but functions identically only if the user knows which pen they're holding.

Switching from Ozempic pens to compounded semaglutide vials (or vice versa) is a larger cognitive shift and is covered in our compounded semaglutide dosing guide.

Storage, expiration, and pen malfunction warnings

Before first use: store the pen in the refrigerator at 36 to 46°F (2 to 8°C). Do not freeze. Frozen semaglutide degrades and should be discarded. The pen is good until the expiration date printed on the label if kept refrigerated.

After first use: store at room temperature (up to 86°F / 30°C) or continue refrigerating. The pen is good for 56 days after first use, regardless of storage temperature. Write the discard date on the pen label when you perform the first injection.

Travel: the pen can be stored at room temperature during travel for up to 56 days (cumulative with home storage time). Use an insulated case if traveling in environments above 86°F. TSA allows pens in carry-on bags. Keep the pen in its original carton to avoid questions.

Discoloration: semaglutide should be clear and colorless. The Instructions for Use say the solution must be clear and colorless; do not use the pen if the solution is cloudy or colored. Pink, red, brown, or cloudy solution indicates degradation or contamination. Discard the pen.

Pen malfunction indicators:

• Dose selector will not rotate, or rotates without clicking.
• Dose counter window is blank, cracked, or displays an error symbol.
• Injection button will not depress, or depresses without resistance.
• Solution leaks from the cartridge holder or needle attachment point.

Do not attempt to repair a malfunctioning pen. Contact the pharmacy for a replacement. Novo Nordisk does not publish a device failure rate; mechanical failures are uncommon but do occur.

If you inject a partial dose due to pen malfunction, do not attempt to "make up" the missing amount with a second injection from a new pen. The pharmacokinetics of split doses are unpredictable. Contact your provider for guidance.

FormBlends clinical pattern: what we see in pen-to-vial transitions

Across our patient population, the most common reason for switching from Ozempic pens to compounded semaglutide is cost, not dissatisfaction with the pen mechanism. Patients on the 2mg pen pay an average of $968 per month without insurance (GoodRx data, April 2026). Compounded semaglutide at the same 2mg weekly dose averages $297 per month through FormBlends.

The second most common reason is dose flexibility. The 2mg pen's 0.25mg increments are sufficient for most patients, but some require intermediate titration steps (e.g., 0.6mg, 0.8mg, 1.2mg) to manage side effects. Compounded semaglutide from a vial allows any dose within the concentration range.

The pattern we see in the reverse direction (vial to pen) is less common but notable. Patients switching to pens cite convenience (no drawing, no reconstitution if they were using lyophilized powder) and travel ease (pens are TSA-friendly and require no refrigeration after first use). The trade-off is cost and dose rigidity.

One unexpected pattern: patients who start on compounded semaglutide and later switch to Ozempic pens report a higher rate of injection-site reactions in the first month post-switch. The likely cause is needle gauge difference. Most compounding pharmacies recommend 31-gauge, 5/16-inch needles for vial-based injections. Novo Nordisk pen needles are typically 32-gauge, 4mm or 6mm. The shorter, thinner needle causes less trauma but requires more precise subcutaneous technique. Patients accustomed to the longer needle sometimes inject the pen needle intramuscularly by accident, causing localized pain and slower absorption.

FAQ

Can I dial 0.5 mg on the Ozempic 2 mg pen?

No. The yellow-label 2 mg pen can only select 2 mg. A 0.5 mg dose comes from the red-label pen, whose counter shows 0.25 or 0.5. Do not try to reach 0.5 mg by counting clicks on the 2 mg pen.

Can I use the 2mg pen for a 0.25mg starting dose?

Mechanically yes, but clinically no. The 0.25mg/0.5mg pen is designed for titration and prevents accidental over-dosing. Use the correct pen for your phase of treatment.

What if the dose selector stops before I reach my prescribed dose?

The pen has insufficient medication remaining to deliver the full dose. Use what's available (the dose shown in the window), then start a new pen for your next injection. Do not attempt to split the remaining dose across two injections.

How do I know if I held the injection button long enough?

Count slowly to 6 after the dose counter returns to zero. If you're unsure, err on the side of holding longer. Holding for 8 or 10 seconds causes no harm. Releasing at 3 or 4 seconds under-doses you.

Can I reuse pen needles to save money?

No. Reused needles are duller, increase injection pain, raise infection risk, and can introduce air into the cartridge. Pen needles cost approximately $0.15 each when bought in bulk. The risk is not worth the savings.

What's the difference between the Ozempic 2mg pen and the Wegovy pen?

Wegovy pens deliver semaglutide at higher doses (up to 2.4mg) and use a different pen design with a fixed-dose mechanism (no dose selector). Ozempic 2mg pens have an adjustable dose selector and max out at 2mg. The medication is chemically identical.

Why does my pen click while I dial 2 mg, and how much is actually in the pen?

The clicks you hear while dialing are selector feedback, not eight 0.25 mg steps; the counter should read 2 when the dose is set. The yellow-label pen holds 8 mg of semaglutide in 3 mL and delivers four 2 mg doses.

Can I dial the dose selector backward if I overshoot?

Yes. Rotate counterclockwise to reduce the dose. The pen will click backward. Verify the dose counter window before injecting.

What if I accidentally inject 1mg instead of 0.5mg?

Contact your provider. Do not skip your next dose to "average it out." The most common instruction is to monitor for nausea and vomiting and resume your normal dose the following week. Doubling your dose once is unlikely to cause serious harm but can increase side effects.

How do I dispose of an empty or expired Ozempic pen?

Remove the needle and dispose of it in a sharps container. The pen itself can go in household trash in most jurisdictions, but check your local regulations. Some pharmacies accept pens for medical waste disposal.

Can I share my Ozempic pen with a family member if we're both prescribed the same dose?

Absolutely not. Sharing pens transmits bloodborne pathogens even if you change the needle. Each pen is single-patient use only.

Why does the dose counter sometimes show a line through the zero?

The line indicates the pen is ready for dose selection but no dose is currently dialed. It's the "home" position. After injection, the counter returns to this state.

Related guides

• How Many Clicks in an Ozempic 2mg Pen? A Click-by-Click Breakdown for Every Dose Strength
• How Many Clicks Is 2mg on an Ozempic Pen? The Complete Dose Dial Chart
• The Ozempic Click Chart: How Many Clicks Equal Each Dose, for All Three Pen Strengths
• Ozempic 8 mg Pen Click Chart: How Many Clicks for Each Dose
• How Many Clicks in a 4 mg Ozempic Pen? A Click-by-Click Breakdown for Every Dose
• How Many Clicks in a 1 mg Ozempic Pen? A Click-by-Click Dosing Guide for Every Strength
• Tool: dosage calculator

Sources

1. Kalra S et al. Injection technique in diabetes: a systematic review of global recommendations. Diabetes Therapy. 2023;14(1):223-238.
2. Novo Nordisk. Ozempic (semaglutide) injection prescribing information (Rev. 05/2026) and Instructions for Use (revised June 2026). https://www.novo-pi.com/ozempic.pdf
3. DailyMed. Ozempic label, section 16 How Supplied. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
4. Blonde L et al. Patient preference and satisfaction with GLP-1 receptor agonist delivery devices. Postgraduate Medicine. 2023;135(6):567-574.
5. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. 2022.
6. Novo Nordisk. Ozempic pen dosing page, August 2026. https://www.ozempic.com/ozempic-pen/dosing.html
7. GoodRx. Ozempic pricing data. Accessed April 2026.
8. Aroda VR et al. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine. The Lancet Diabetes & Endocrinology. 2017;5(5):355-366.
9. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989-1002.
10. Marso SP et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine. 2016;375(19):1834-1844.
11. Pratley RE et al. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7). The Lancet Diabetes & Endocrinology. 2018;6(4):275-286.
12. Ahmann AJ et al. Efficacy and safety of once-weekly semaglutide versus exenatide ER. Diabetes Care. 2018;41(2):258-266.
13. Lingvay I et al. Effect of semaglutide vs placebo on body weight in adults with type 2 diabetes. JAMA. 2022;327(2):138-150.
14. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance. JAMA. 2021;325(14):1414-1425.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.